Related Experiment Video
Updated: Nov 9, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013
Shih-Wei Lai1,2, Kuan-Fu Liao3,4, Cheng-Li Lin5
1College of Medicine, China Medical University, Taichung, Taiwan.
Objective:
The objective of the study was to evaluate the prevalences and trends of multimorbidity and polypharmacy in older adults in Taiwan.
Methods:
An observational study was performed using the 2000-2013 database of the Taiwan National Health Insurance Program (analysis in 2018). Participants ≥65 years were included in the study. Multimorbidity was defined as participants having two or more chronic diseases annually. Polypharmacy was defined as the average daily number of prescribed medications ≥5.
Results:
The prevalences of multimorbidity were 42.4% in 2000 and 56% in 2013. The prevalences of polypharmacy were 22.9% in 2000 and 32.1% in 2013.
Conclusions:
From 2000 to 2013, multimorbidity and polypharmacy were prevalent among older adults in Taiwan. Public health efforts to intervene the primary prevention for chronic diseases should be considered in older adults.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Longitudinal Research
